Distribution of the primary site in malignant pericardial effusion
| Authors | Global (N) | Age (years, mean±SD) | Male (%) | Primary malignancy | |||||
| Lung (%) | Breast (%) | Haematological (%) | Gastrointestinal (%) | Other (%) | Unknown (%) | ||||
| Saab et al 14* | 364 | 63 | 176 (48) | 20/47 (42.5) | 12/47 (25.5) | 3/47 (6.4) | 7/47 (15) | 5/47 (10.6) | 0 |
| Gornik et al 13† | 219 | 58±1 | 116 (53) | 33/96 (34.4) | 16/96 (16.7) | 13/96 (13.5) | 9/96 (9.4) | 17/96 (17.7) | 8/96 (8.3) |
| Sánchez-Enrique et al 8‡ | 136 | 65±17 | 75 (55) | 24/44 (54.6) | 8/44 (18.2) | 2/44 (4.5) | 2/44 (4.5) | 5/44 (11.4) | 3/44 (6.8) |
| Numico et al 11 | 22 | 60 | 6 (27) | 14/22 (63.7) | 5/22 (22.7) | NR | 1/22 (4.5) | NR | 2/22 (9,1) |
| Çelik et al 3 | 175 | 54±14 | 99 (56.6) | 89/175 (50.9) | 26/175 (14.9) | 26/175 (14.9) | NR | 34/175 (19.3) | NR |
| Kim et al 16 | 98 | 52±12 | 49 (50) | 74/98 (75.5) | 10/98 (10.2) | 1/98 (1.0) | 5/98 (5.1) | 8/98 (8.2) | 0 |
| Patel et al 17§ | 88 | 60±14 | 35 (40) | 33/88 (38) | 17/88 (19) | 17/88 (19) | 9/88 (10) | 15/88 (17) | NR |
| El Haddad et al 5 | 212 | 55±16 | 111 (52) | 61/212 (29) | 22/212 (10) | 61/212 (29) | 16/212 (7.5) | 52/212 (24.5) | NR |
| Rafique et al 6¶ | 157 | 62±18 | 85 (54) | 12/42 (28.6) | 8/42 (19) | 11/42 (26.2) | 7/42 (16.7) | 7/42 (16.7) | 0 |
*51 patients of the 364 analysed had a malignant pericardial effusion. 47 of 51 had a history of malignancy (19 male; 28 female).
†96 of 219 patients had cancer-related pericardial effusion.
‡Malignancy was responsible for pericardial effusion in 44 of 136 patients.
§Two patients had concomitant two types of cancer.
¶42 of 157 patients had malignancy. 3 patients had concomitant two types of cancer.
NR not reported.N, number of patients.